Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
21 hedge funds and large institutions have $50.3M invested in Enzymotec Ltd in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 6 closing their positions.
13% less capital invested
Capital invested by funds: $58.1M → $50.3M (-$7.79M)
19% less funds holding
Funds holding: 26 → 21 (-5)
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$2.42M |
| 2 |
Renaissance Technologies
New York
|
+$85.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$21.4K |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.17K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$833 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GA
Gagnon Advisors
New York
|
-$2.67M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$341K |
| 3 |
GS
Gagnon Securities
New York
|
-$234K |
| 4 |
LCM
Laurion Capital Management
New York
|
-$124K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$59K |
ENZY Hedge Fund Activity: Q2 2017 in Review
21 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q2 2017, worth a combined $50.3M — down 13% from $58.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ENZY and 2 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 4 added.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $2.42M. The largest seller was Gagnon Advisors, exiting entirely with an estimated $2.67M sold.
- 21 institutional investors held Enzymotec Ltd (ENZY) as of Q2 2017, down from 26 in Q1 2017.
- Funds reported $50.3M of Enzymotec Ltd stock for Q2 2017, down 13% quarter-over-quarter.
- 2 funds opened new Enzymotec Ltd positions in Q2 2017 and 6 closed out, a net change of -4 holders.
- The largest Enzymotec Ltd buyer in Q2 2017 was Janus Henderson Group, an estimated $2.42M added.
- The largest Enzymotec Ltd seller in Q2 2017 was Gagnon Advisors, an estimated $2.67M sold.
Based on aggregated 13F filings for Q2 2017.